Prognostic Model for Whole Brain Radiotherapy
/ Frederik Svendsen
First-Line Lorlatinib in ALK-Positive NSCLC
/ Jon Alexander Lykkegaard Andersen
Oligometastatic Cancer: Evidence from a Danish National Cohort Study
/ Michael Ruben Teindl Laursen
Testing New Therapies for Ovarian Cancer in a 3D Model
/ Christiane Helgestad Gjerde / Katrin Kleinmanns / Emmet McCormack / Line Bjørge
De-escalating Immunotherapy in dMMR Colorectal Cancer: Results from the RESET Trials
/ Laurids Østergaard Poulsen
Identifying Neurogenic Orthostatic Hypotension in Polyneuropathy
/ Markus Hedin Fedder
Patient monitoring and decision-making in CIDP
/ Lars Kjøbsted Markvardsen / Jan Andreasen
Evaluating Treatment Response in CIDP: Clinical Precision in a Heterogeneous Disorder
/ Aki Hietaharju / Jan Andreasen
T-DXd in Patients with High-Risk HER2-Positive Early Breast Cancer – Are We Ready to Change Practice?
/ Henrik Lindman / Jan Andreasen
Combination of Enfortumab Vedotin and Pembrolizumab Has Radically Improved Bladder Cancer Treatment
/ Jakob Lauritsen / Jan Andreasen
BestPractice Nordic appoints Gitte Broholm as new Chief Commercial Officer
/ BestPractice Nordic









